Skip to main content

Table 1 Patient demographic and treatment characteristics; percentiles are listed parenthetically.

From: Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme

Characteristic    Series Primary disease Recurrent disease
    (n = 42) (n = 33) (n = 9)
Age (yrs)      
  Median   60 63 46
  Range   20–86 40–86 20–59
Sex      
  Male   27 (64) 20 (60) 7 (78)
  Female   15 (36) 13 (40) 2 (22)
Surgery      
  Biopsy alone/unresectable   8 (19) 6 (19) 2 (22)
  Debulking/resection   34 (81) 27 (81) 7 (78)
   Complete resection 13(31) 10 (30) 3 (33)
   Partial resection 21(50) 17 (51) 4 (44)
Chemotherapy None   19 (45) 17 (51) 2 (22)
  Any agent   23 (55) 16 (49) 7 (78)
   Carmustine (iv) 5 (12) 2 (6) 3 (33)
   Carmustine (wafer) 2 (5) 1 (3) 1 (11)
   Lomustine 1 (2) 1 (3) -
   Irinotecan 3(7) 2 (6) 1 (11)
   Penicillamine 3 (7) 3 (9) -
   Temozolomide 9(21) 7 (21) 2 (22)
IMRT technique      
  IMRT Only   30 (72) 22 (66) 8 (89)
  3DCRT + IMRT boost   12 (28) 11 (33) 1 (11)